The share price of DexCom, Inc. [NASDAQ: DXCM] inclined by $252.21, presently trading at $288.20. The company’s shares saw 168.25% gains compared to the lowest price in the period of the last 52 weeks, set at $107.44 recorded on 02/13/20. The last few days have been benevolent to the share price as DXCM jumped by +20.22% during the last week, even though the stock is still down by -2.11% compared to 48.57 of all time high it touched on 02/14/20. However, the stock had a strong performance during the past 3 months, roughly gaining 7.30%, while additionally gaining 69.21% during the last 12 months. DexCom, Inc. is said to have a 12-month price target set at $246.50. That means that the stock has a strong potential to acquire -41.7% decrease from the current trading price.

DexCom, Inc. [NASDAQ:DXCM]: Analyst Rating and Earnings

Its stock price has been found in the range of 107.44 to 254.70. This is compared to its latest closing price of $252.21.

Pay attention to the next-scheduled financial results for this company to be released, which is slated for Wed 6 May (In 82 Days).

Fundamental Analysis of DexCom, Inc. [DXCM]

Now let’s turn to look at profitability: with a current Operating Margin for DexCom, Inc. [DXCM] sitting at -17.54 and its Gross Margin at +64.36, this company’s Net Margin is now -12.70%. These metrics indicate that this company is not generating as much profit, after accounting for expenses, compared to its market peers.

This company’s Return on Total Capital is -14.86, and its Return on Invested Capital has reached -11.10%. Its Return on Equity is -23.48, and its Return on Assets is -9.01. These metrics suggest that this DexCom, Inc. does a poor job of managing its assets, and likely won’t be able to provide successful business outcomes for its investors in the near term.

Turning to investigate this organization’s capital structure, DexCom, Inc. [DXCM] has generated a Total Debt to Total Equity ratio of 153.41. Similarly, its Total Debt to Total Capital is 60.54, while its Total Debt to Total Assets stands at 53.11. Looking toward the future, this publicly-traded company’s Long-Term Debt to Equity is -7.97, and its Long-Term Debt to Total Capital is 153.41.

What about valuation? This company’s Enterprise Value to EBITDA is 112.98. The Enterprise Value to Sales for this firm is now 14.62, and its Total Debt to Enterprise Value stands at 0.10. DexCom, Inc. [DXCM] has a Price to Book Ratio of 16.26, a Price to Cash Flow Ratio of 85.77 and P/E Ratio of 266.38. These metrics suggest that this publicly-traded organization will not likely result in investment gains.

Shifting the focus to workforce efficiency, DexCom, Inc. [DXCM] earns $368,429 for each employee under its payroll. Similarly, this company’s Receivables Turnover is 5.72 and its Total Asset Turnover is 0.73. This publicly-traded organization’s liquidity data is also interesting: its Quick Ratio is 7.32 and its Current Ratio is 7.64. This company, considering these metrics, has a healthy ratio between its short-term liquid assets and its short-term liabilities, making it a less risky investment.

DexCom, Inc. [DXCM] has 91.30M shares outstanding, amounting to a total market cap of $23.03B. Its stock price has been found in the range of 107.44 to 254.70. At its current price, it has moved up by 13.15% from its 52-week high, and it has moved up 168.25% from its 52-week low.

This stock’s Beta value is currently 0.80, which indicates that it is 3.20% more volatile that the wider market. This stock’s Relative Strength Index (RSI) is at 85.66. This RSI suggests that DexCom, Inc. is currently Overbought.

Conclusion: Is DexCom, Inc. [DXCM] a Reliable Buy?

DexCom, Inc. [DXCM] stock is presenting a less attractive investment opportunity when compared to similarly-sized corporations in the same industry. The price performance of these shares has not shown much promise, and the financial results that this company has recently delivered present a highly risky investment.